Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
10:44:56 EDT Sat 27 Apr 2024
Enter Symbol
or Name
USA
CA



News for U:NEO from 2023-04-27 to 2024-04-26 - 26 items News ReleasesIn The NewsOther CAUS
DateSymPriceTypeHeadline
2024-04-18 07:05U:NEONews ReleaseNeoGenomics Announces Senior Leadership Promotions
2024-04-09 07:00U:NEONews ReleaseNeoGenomics to Report First Quarter 2024 Financial Results on April 30, 2024
2024-03-27 08:30U:NEONews ReleaseNeoGenomics Showcases Commitment to Transforming Cancer Patient Care at AACR 2024 Annual Meeting
2024-03-20 07:00U:NEONews ReleaseNeoGenomics Releases Inaugural Environmental, Social, and Governance (ESG) Report
2024-03-01 07:05U:NEONews ReleaseNeoGenomics to Participate in the TD Cowen 44th Annual Health Care Conference
2024-02-20 16:05U:NEONews ReleaseNeoGenomics Reports Fourth Quarter and Full Year 2023 Results
2024-02-01 07:05U:NEONews ReleaseNeoGenomics Signs Working with Cancer Pledge in Support of Employees
2024-01-30 09:15U:NEONews ReleaseMultiple Myeloma Therapeutics Market Expected to Reach $4.26 Billion in 2030
2024-01-30 07:05U:NEONews ReleaseNeoGenomics to Report Fourth Quarter and Full Year 2023 Financial Results on February 20, 2024
2024-01-02 07:05U:NEONews ReleaseNeoGenomics to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
2023-12-28 08:11U:NEONews ReleaseNeoGenomics to Appeal Ruling
2023-12-05 08:02U:NEONews ReleaseNeoGenomics to Present New Data at San Antonio Breast Cancer Symposium Highlighting Utility of RaDaR for Therapy Response
2023-11-14 07:02U:NEONews ReleaseNeoGenomics to Participate at the Piper Sandler 35th Annual Healthcare Conference
2023-11-06 16:07U:NEONews ReleaseNeoGenomics Reports Third Quarter 2023 Results
2023-10-24 07:02U:NEONews ReleaseNeoGenomics Announces the Commercial Availability of Two New Tests, Expanding Its Next-Generation Sequencing and Lung Cancer Portfolios
2023-10-17 09:21U:NEONews ReleaseNeoGenomics to Report Third Quarter 2023 Financial Results on November 6, 2023
2023-08-08 07:02U:NEONews ReleaseNeoGenomics Reports Second Quarter 2023 Results
2023-07-27 07:01U:NEONews ReleaseNeoGenomics Announces Medicare Coverage for RaDaR Assay for Minimal Residual Disease and Recurrence in Breast Cancer
2023-07-18 07:10U:NEONews ReleaseNeoGenomics to Report Second Quarter 2023 Financial Results on August 8, 2023
2023-06-29 07:01U:NEONews ReleaseNeoGenomics Expands Board of Directors with Appointments of Three Independent Directors
2023-06-15 16:46U:NEONews ReleaseNeoGenomics' RaDaR Assay for Minimal Residual Disease Receives First Commercial Coverage
2023-06-05 07:01U:NEONews ReleaseNeoGenomics and German Breast Group Announce New Data Demonstrating Clinical Potential of the RaDaR MRD Assay in HR+/HER2- Breast Cancer
2023-06-01 07:02U:NEONews ReleaseNeoGenomics to Participate at the Goldman Sachs 44th Annual Global Healthcare Conference
2023-05-30 07:01U:NEONews ReleaseNeoGenomics to Showcase the Transformational Impact of RaDaR(R) Assay for Molecular Residual Disease and Recurrence Monitoring at ASCO
2023-05-08 16:08U:NEONews ReleaseNeoGenomics Reports First Quarter 2023 Results
2023-05-03 07:01U:NEONews ReleaseNeoGenomics to Participate at the BofA Securities 2023 Healthcare Conference